Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Acute Repetitive Seizures Market from 2024 to 2025?
The market size for acute repetitive seizures has seen a swift expansion in the past few years. It is projected to expand from $3.13 billion in 2024 to $3.51 billion in 2025, growing at a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth in the historic period include an increase in the prevalence of epilepsy, higher awareness about seizure control, an uptick in the utilization of rescue medicines, advancements in diagnostic techniques, and broader access to healthcare services.
What Is the Projected Market Size of the Acute Repetitive Seizures Market?
In the coming years, the market for acute repetitive seizures is anticipated to experience substantial growth. It is predicted to escalate to $5.44 billion in 2029 with a compound annual growth rate (CAGR) of 11.6%. The augmentation during this projected period can be ascribed to the increasing demand for non-invasive methods of treatment, heightened investment in epilepsy studies, growing use of wearable devices for seizure monitoring, proliferation of telemedicine in the field of neurology, and governmental efforts towards improving epilepsy care. Noteworthy advancements for the forecasted timeline consist of the use of AI in predicting seizures, assimilation of digital health solutions, broadening of clinical trials for innovative treatments, emergence of gene therapies targeted towards epilepsy, and creation of new drug formulas.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23292&type=smp
Who are the Major Competitors in the Acute Repetitive Seizures Market Outlook?
Major companies operating in the acute repetitive seizures market are Pfizer Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Bausch Health US LLC. , UCB S.A., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Endo International plc, Lupin Limited, Amneal Pharmaceuticals LLC, Aquestive Therapeutics Inc., Neurelis Inc., Grupo Ferrer Internacional S.A., UpsherSmith Laboratories LLC , Aculys Pharma Inc.
What Is Fueling Growth in the Acute Repetitive Seizures Market?
The upward trend of neurological disorders is anticipated to drive the expansion of the acute repetitive seizures market. Neurological disorders, which impact the brain, nerves, or spinal cord and can lead to issues with movement, speech, cognition, or bodily functions, are increasingly common due to the elderly population, who are more prone to brain degeneration. This increases the risk of diseases such as Alzheimer’s, Parkinson’s and stroke. In particular, acute repetitive seizures can exacerbate neurological disorders by increasing the likelihood of neuronal damage, cognitive loss, and long-term issues, underscoring the need for early intervention. For example, the Alzheimer’s Association, a US-based voluntary health organization, reports that in March 2023, around 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia. This figure is anticipated to double to 13.8 million by 2060. Thus, the growing incidence of neurological disorders is fuelling the acute repetitive seizures market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=23292&type=smp
Which Acute Repetitive Seizures Market Segments Are Growing the Fastest?
The acute repetitive seizures market covered in this report is segmented –
1) By Drug Type: Benzodiazepines, Antiepileptic Drugs, Barbiturates, Other Drug Types
2) By Route Of Administration: Intranasal, Rectal, Oral, Other Routes Of Administrations
3) By End User: Hospitals, Clinics, Home Care Settings
Subsegments:
1) By Benzodiazepines: Diazepam, Lorazepam, Midazolam, Clonazepam, Alprazolam
2) By Antiepileptic Drugs: Levetiracetam, Phenytoin, Valproate, Carbamazepine, Lamotrigine
3) By Barbiturates: Phenobarbital, Primidone
4) By Other Drug Types: Corticosteroids, Intravenous Immunoglobulins (IVIG), Cannabinoids
Which Industry Trends Are Shaping the Future of the Acute Repetitive Seizures Market?
Key players in the acute repetitive seizures industry are leading advancements by producing inventive formulations like benzodiazepine buccal film. This serves to amplify drug absorption, quicken the relief from seizures, and augment convenience for patients. Benzodiazepine buccal film, a fine dissoluble film carrying a benzodiazepine substance, is placed inside the cheek to enable speedy absorption via the oral mucosa. It proves beneficial in managing acute repetitive seizures by swiftly delivering the drug into the bloodstream, thus decreasing the duration and occurrence of seizures. As an example, Aquestive Therapeutics Inc., a pharmaceutical company based in the US, revealed in December 2024, that the U.S. Food and Drug Administration (FDA) granted its product, Libervant (diazepam) buccal film, an orphan drug exclusivity (ODE) for seven years. Libervant is employed for the acute therapy of episodic, freuent seizures, encompassing seizure clusters and acute repetitive seizures. This diazepam-based buccal film is administered buccally and functions by elevating the impact of gamma-aminobutyric acid (GABA) to lessen seizure activity, acting as a central nervous system depressant.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/acute-repetitive-seizures-global-market-report
Which Countries Are Leading the Acute Repetitive Seizures Market?
North America was the largest region in the acute repetitive seizures market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute repetitive seizures market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23292
This Report Delivers Insight On:
1. How big is the acute repetitive seizures market, and how is it changing globally?
2. Who are the major companies in the acute repetitive seizures market, and how are they performing?
3. What are the key opportunities and risks in the acute repetitive seizures market right now?
4. Which products or customer segments are growing the most in the acute repetitive seizures market?
5. What factors are helping or slowing down the growth of the acute repetitive seizures market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
